Reader Response: Long-term Neurologic Safety in Patients With B-Cell Lymphoma Treated With Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy. Tan BJ, Chan LL, Tan EK. Neurology 2023;100:688.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Tan BJ, Chan LL, Tan EK. Reader Response: Long-term Neurologic Safety in Patients With B-Cell Lymphoma Treated With Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy. Neurology 2023;100:688.
PMID: 37012060